Literature DB >> 7002564

Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction.

T L Kho, J W Henquet, R Punt, W H Birkenhäger, K H Rahn.   

Abstract

The comparative hemodynamic effects of dobutamine and dopamine were studied in 6 patients with low cardiac output resulting from acute myocardial infarction. Plasma levels of noradrenaline and renin were measured before and during a 5 microgram/kg/min infusion of each of the drugs. Dobutamine had a more pronounced chronotropic effect, increased the systolic arterial pressure more and decreased the systemic vascular resistance less than dopamine at doses which had comparable effects on cardiac output. Dobutamine stimulated renin release, which might partly be the cause of the increased systolic arterial pressure. The drug reduced the plasma level of noradrenaline, which might be explained as a reflex reduction in sympathetic tone. Dopamine, however, did not stimulate renin release but it did enhance the plasma level of noradrenaline, which might be due mainly to the release of endogenous noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002564     DOI: 10.1007/bf00563001

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  29 in total

1.  Cardiovascular effects of isoproterenol in normal subjects and subjects with congestive heart failure.

Authors:  H T DODGE; J D LORD; H SANDLER
Journal:  Am Heart J       Date:  1960-07       Impact factor: 4.749

2.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

Authors:  S F Vatner; R J McRitchie; E Braunwald
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

3.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

4.  Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol.

Authors:  H J Smith; A Oriol; J Morch; M McGregor
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

5.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

6.  Ineffectiveness of isoproterenol in shock due to acute myocardial infarction.

Authors:  R M Gunnar; H S Loeb; R J Pietras; J R Tobin
Journal:  JAMA       Date:  1967-12-25       Impact factor: 56.272

7.  Hemodynamic effect of dobutamine in patients with severe heart failure.

Authors:  N Akhtar; E Mikulic; J N Cohn; M H Chaudhry
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

8.  Hemodynamic effects of dobutamine in patients following open heart surgery.

Authors:  T Sakamoto; T Yamada
Journal:  Circulation       Date:  1977-03       Impact factor: 29.690

9.  Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.

Authors:  C V Leier; P T Heban; P Huss; C A Bush; R P Lewis
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

10.  Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease.

Authors:  R Rosenblum; A R Tai; D Lawson
Journal:  J Pharmacol Exp Ther       Date:  1972-11       Impact factor: 4.030

View more
  7 in total

Review 1.  Cardiogenic shock.

Authors:  C E Handler
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

2.  Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction.

Authors:  T L Kho; J W Henquet; R Punt; W H Birkenhäger; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Vasoactive agents and production of thrombosis during intravascular coagulation. 3. Comparative effects of catecholamines.

Authors:  J G Latour; C Léger-Gauthier
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

4.  Pharmacokinetics and plasma-concentration-effect relationships of prenalterol in cardiac failure.

Authors:  E J Sainsbury; D Fitzpatrick; H Ikram; M G Nicholls; E A Espiner; J J Ashley
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Haemodynamic changes during the apnoea test for diagnosis of brain death.

Authors:  T Ebata; Y Watanabe; K Amaha; Y Hosaka; S Takagi
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

6.  Correlation between the pharmacokinetics and pharmacodynamics of dopamine in healthy subjects.

Authors:  U Gundert-Remy; J Penzien; R Hildebrandt; W Mäurer; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Effects of dopamine infusion on plasma catecholamines in preterm and term newborn infants.

Authors:  H Stopfkuchen; K Racké; H Schwörer; A Queisser-Luft; K Vogel
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.